Rethinking patent law:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge, Mass.
Harvard University Press
2012
|
Schlagworte: | |
Beschreibung: | Print version record |
Beschreibung: | 1 online resource (279 pages) illustrations |
ISBN: | 9780674064966 0674064968 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV045344903 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 181206s2012 |||| o||u| ||||||eng d | ||
020 | |a 9780674064966 |9 978-0-674-06496-6 | ||
020 | |a 0674064968 |9 0-674-06496-8 | ||
035 | |a (ZDB-4-ENC)ocn796813130 | ||
035 | |a (OCoLC)796813130 | ||
035 | |a (DE-599)BVBBV045344903 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
082 | 0 | |a 346.7304/86 |2 23 | |
100 | 1 | |a Feldman, Robin |e Verfasser |4 aut | |
245 | 1 | 0 | |a Rethinking patent law |c Robin Feldman |
264 | 1 | |a Cambridge, Mass. |b Harvard University Press |c 2012 | |
300 | |a 1 online resource (279 pages) |b illustrations | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Print version record | ||
505 | 8 | |a Scientific and technological innovations are forcing patent law into the spotlight and revealing its many glaring inadequacies. Take, for example, the patent case that almost shut down the BlackBerry, or the growing phenomenon of patent trolling, in which patents are acquired for the sole purpose of entrapping companies whose products relate to them. And patents on genes have everyone up in arms—and our courts confused. Robin Feldman explains why patents are causing so much trouble. The problem lies in our assumption that patents set clear boundaries for rights to an invention. In reality, they do no such thing. The very nature of inventions makes them impossible to describe unambiguously for all time. When something is so new that we do not understand yet how it works, what it is capable of doing, or how it could be applied—as is often the case in biotechnology—description is necessarily slippery. Instead of hoping for clear boundaries, and moaning when we don’t get them, Rethinking Patent Law urges lawmakers to focus on what the law can do well: craft rules that anticipate the bargaining that will occur as rights unfold. By steering clear of laws that distort the bargaining process, lawmakers can help courts answer difficult questions, such as whether genes, software, and business methods constitute patentable subject matter, whether patents in the life sciences should control inventions that have yet to be discovered, and how to resolve the battles between pharmaceutical companies and generics | |
650 | 7 | |a LAW / Administrative Law & Regulatory Practice |2 bisacsh | |
650 | 7 | |a LAW / Intellectual Property / Patent |2 bisacsh | |
650 | 7 | |a Patent laws and legislation |2 fast | |
650 | 4 | |a Patent laws and legislation |z United States | |
650 | 0 | 7 | |a Patentrecht |0 (DE-588)4044884-8 |2 gnd |9 rswk-swf |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Patentrecht |0 (DE-588)4044884-8 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Feldman, Robin |t Rethinking patent law |d Cambridge, Mass. : Harvard University Press, 2012 |z 9780674064683 |
912 | |a ZDB-4-ENC | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030731606 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804179165095657472 |
---|---|
any_adam_object | |
author | Feldman, Robin |
author_facet | Feldman, Robin |
author_role | aut |
author_sort | Feldman, Robin |
author_variant | r f rf |
building | Verbundindex |
bvnumber | BV045344903 |
collection | ZDB-4-ENC |
contents | Scientific and technological innovations are forcing patent law into the spotlight and revealing its many glaring inadequacies. Take, for example, the patent case that almost shut down the BlackBerry, or the growing phenomenon of patent trolling, in which patents are acquired for the sole purpose of entrapping companies whose products relate to them. And patents on genes have everyone up in arms—and our courts confused. Robin Feldman explains why patents are causing so much trouble. The problem lies in our assumption that patents set clear boundaries for rights to an invention. In reality, they do no such thing. The very nature of inventions makes them impossible to describe unambiguously for all time. When something is so new that we do not understand yet how it works, what it is capable of doing, or how it could be applied—as is often the case in biotechnology—description is necessarily slippery. Instead of hoping for clear boundaries, and moaning when we don’t get them, Rethinking Patent Law urges lawmakers to focus on what the law can do well: craft rules that anticipate the bargaining that will occur as rights unfold. By steering clear of laws that distort the bargaining process, lawmakers can help courts answer difficult questions, such as whether genes, software, and business methods constitute patentable subject matter, whether patents in the life sciences should control inventions that have yet to be discovered, and how to resolve the battles between pharmaceutical companies and generics |
ctrlnum | (ZDB-4-ENC)ocn796813130 (OCoLC)796813130 (DE-599)BVBBV045344903 |
dewey-full | 346.7304/86 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 346 - Private law |
dewey-raw | 346.7304/86 |
dewey-search | 346.7304/86 |
dewey-sort | 3346.7304 286 |
dewey-tens | 340 - Law |
discipline | Rechtswissenschaft |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03165nmm a2200445zc 4500</leader><controlfield tag="001">BV045344903</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181206s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780674064966</subfield><subfield code="9">978-0-674-06496-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0674064968</subfield><subfield code="9">0-674-06496-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-ENC)ocn796813130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)796813130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045344903</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.7304/86</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Feldman, Robin</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rethinking patent law</subfield><subfield code="c">Robin Feldman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">Harvard University Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (279 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Scientific and technological innovations are forcing patent law into the spotlight and revealing its many glaring inadequacies. Take, for example, the patent case that almost shut down the BlackBerry, or the growing phenomenon of patent trolling, in which patents are acquired for the sole purpose of entrapping companies whose products relate to them. And patents on genes have everyone up in arms—and our courts confused. Robin Feldman explains why patents are causing so much trouble. The problem lies in our assumption that patents set clear boundaries for rights to an invention. In reality, they do no such thing. The very nature of inventions makes them impossible to describe unambiguously for all time. When something is so new that we do not understand yet how it works, what it is capable of doing, or how it could be applied—as is often the case in biotechnology—description is necessarily slippery. Instead of hoping for clear boundaries, and moaning when we don’t get them, Rethinking Patent Law urges lawmakers to focus on what the law can do well: craft rules that anticipate the bargaining that will occur as rights unfold. By steering clear of laws that distort the bargaining process, lawmakers can help courts answer difficult questions, such as whether genes, software, and business methods constitute patentable subject matter, whether patents in the life sciences should control inventions that have yet to be discovered, and how to resolve the battles between pharmaceutical companies and generics</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Administrative Law & Regulatory Practice</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Intellectual Property / Patent</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent laws and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent laws and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Patentrecht</subfield><subfield code="0">(DE-588)4044884-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Feldman, Robin</subfield><subfield code="t">Rethinking patent law</subfield><subfield code="d">Cambridge, Mass. : Harvard University Press, 2012</subfield><subfield code="z">9780674064683</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-ENC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030731606</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
geographic | USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV045344903 |
illustrated | Illustrated |
indexdate | 2024-07-10T08:15:31Z |
institution | BVB |
isbn | 9780674064966 0674064968 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030731606 |
oclc_num | 796813130 |
open_access_boolean | |
physical | 1 online resource (279 pages) illustrations |
psigel | ZDB-4-ENC |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Harvard University Press |
record_format | marc |
spelling | Feldman, Robin Verfasser aut Rethinking patent law Robin Feldman Cambridge, Mass. Harvard University Press 2012 1 online resource (279 pages) illustrations txt rdacontent c rdamedia cr rdacarrier Print version record Scientific and technological innovations are forcing patent law into the spotlight and revealing its many glaring inadequacies. Take, for example, the patent case that almost shut down the BlackBerry, or the growing phenomenon of patent trolling, in which patents are acquired for the sole purpose of entrapping companies whose products relate to them. And patents on genes have everyone up in arms—and our courts confused. Robin Feldman explains why patents are causing so much trouble. The problem lies in our assumption that patents set clear boundaries for rights to an invention. In reality, they do no such thing. The very nature of inventions makes them impossible to describe unambiguously for all time. When something is so new that we do not understand yet how it works, what it is capable of doing, or how it could be applied—as is often the case in biotechnology—description is necessarily slippery. Instead of hoping for clear boundaries, and moaning when we don’t get them, Rethinking Patent Law urges lawmakers to focus on what the law can do well: craft rules that anticipate the bargaining that will occur as rights unfold. By steering clear of laws that distort the bargaining process, lawmakers can help courts answer difficult questions, such as whether genes, software, and business methods constitute patentable subject matter, whether patents in the life sciences should control inventions that have yet to be discovered, and how to resolve the battles between pharmaceutical companies and generics LAW / Administrative Law & Regulatory Practice bisacsh LAW / Intellectual Property / Patent bisacsh Patent laws and legislation fast Patent laws and legislation United States Patentrecht (DE-588)4044884-8 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Patentrecht (DE-588)4044884-8 s 1\p DE-604 Erscheint auch als Druck-Ausgabe Feldman, Robin Rethinking patent law Cambridge, Mass. : Harvard University Press, 2012 9780674064683 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Feldman, Robin Rethinking patent law Scientific and technological innovations are forcing patent law into the spotlight and revealing its many glaring inadequacies. Take, for example, the patent case that almost shut down the BlackBerry, or the growing phenomenon of patent trolling, in which patents are acquired for the sole purpose of entrapping companies whose products relate to them. And patents on genes have everyone up in arms—and our courts confused. Robin Feldman explains why patents are causing so much trouble. The problem lies in our assumption that patents set clear boundaries for rights to an invention. In reality, they do no such thing. The very nature of inventions makes them impossible to describe unambiguously for all time. When something is so new that we do not understand yet how it works, what it is capable of doing, or how it could be applied—as is often the case in biotechnology—description is necessarily slippery. Instead of hoping for clear boundaries, and moaning when we don’t get them, Rethinking Patent Law urges lawmakers to focus on what the law can do well: craft rules that anticipate the bargaining that will occur as rights unfold. By steering clear of laws that distort the bargaining process, lawmakers can help courts answer difficult questions, such as whether genes, software, and business methods constitute patentable subject matter, whether patents in the life sciences should control inventions that have yet to be discovered, and how to resolve the battles between pharmaceutical companies and generics LAW / Administrative Law & Regulatory Practice bisacsh LAW / Intellectual Property / Patent bisacsh Patent laws and legislation fast Patent laws and legislation United States Patentrecht (DE-588)4044884-8 gnd |
subject_GND | (DE-588)4044884-8 (DE-588)4078704-7 |
title | Rethinking patent law |
title_auth | Rethinking patent law |
title_exact_search | Rethinking patent law |
title_full | Rethinking patent law Robin Feldman |
title_fullStr | Rethinking patent law Robin Feldman |
title_full_unstemmed | Rethinking patent law Robin Feldman |
title_short | Rethinking patent law |
title_sort | rethinking patent law |
topic | LAW / Administrative Law & Regulatory Practice bisacsh LAW / Intellectual Property / Patent bisacsh Patent laws and legislation fast Patent laws and legislation United States Patentrecht (DE-588)4044884-8 gnd |
topic_facet | LAW / Administrative Law & Regulatory Practice LAW / Intellectual Property / Patent Patent laws and legislation Patent laws and legislation United States Patentrecht USA |
work_keys_str_mv | AT feldmanrobin rethinkingpatentlaw |